US12435076B2 - Fluorine-containing pyrimidine compound and method for producing same - Google Patents

Fluorine-containing pyrimidine compound and method for producing same

Info

Publication number
US12435076B2
US12435076B2 US17/768,556 US202017768556A US12435076B2 US 12435076 B2 US12435076 B2 US 12435076B2 US 202017768556 A US202017768556 A US 202017768556A US 12435076 B2 US12435076 B2 US 12435076B2
Authority
US
United States
Prior art keywords
group
carbon atoms
following formula
hydrocarbon group
fluorine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US17/768,556
Other versions
US20240124436A1 (en
Inventor
Junya SEINO
Rie AOTSU
Keisuke Kokin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unimatec Co Ltd
Original Assignee
Unimatec Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimatec Co Ltd filed Critical Unimatec Co Ltd
Assigned to UNIMATEC CO., LTD. reassignment UNIMATEC CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AOTSU, Rie, KOKIN, KEISUKE, SEINO, Junya
Publication of US20240124436A1 publication Critical patent/US20240124436A1/en
Application granted granted Critical
Publication of US12435076B2 publication Critical patent/US12435076B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/78—1,3-Thiazoles; Hydrogenated 1,3-thiazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00—Fungicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Definitions

  • the present disclosure relates to a fluorine-containing pyrimidine compound and a method for producing the same.
  • WO 2017/139603 reports that a compound having a 2-(5-thiazolyl)-pyrimidine structure is effective for a treatment of hypertension, PTSD, depression, pain and the like. From such viewpoints, introduction of substituents to the 4- and 6-positions of the pyrimidine ring has drawn attention in anticipation of further improvement in the activity.
  • Tetrahedron, Vol. 72, 2016, pp. 3250-3255, ACS Catalysis, Vol. 8, 2018, pp. 2839-2843, and Angewandte Chemie International Edition, Vol. 57, 2018, pp. 6926-6929 disclose, on the other hand, a method for synthesizing a pyrimidine compound having a trifluoromethyl group at the 5-position of a pyrimidine ring and substituents at the 4-position and the 6-position. More specifically, Tetrahedron, Vol. 72, 2016, pp. 3250-3255 reports a synthetic method using sodium trifluoromethanesulfinate (Langlois reagent), ACS Catalysis, Vol. 8, 2018, pp.
  • a thiophene ring structure or a thiazole ring structure can be introduced at the 2-position between the two nitrogen atoms on a pyrimidine ring by reacting a specific raw material, and thus have completed the present disclosure.
  • the configuration of the present disclosure is as follows.
  • An aspect of the present disclosure is a fluorine-containing pyrimidine compound represented by the following formula (1), (2) or (3):
  • R represents a hydrocarbon group having 1 to 12 carbon atoms
  • X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —C n F 2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA 1 , —SO m A 1 where m is an integer of 0 to 3, —NA 1 A 2 , —COOA 1 or —CONA 1 A 2
  • Z represents CW or N
  • W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —C n F 2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA 1 , —SO m A 1 where m is an integer of 0 to 3, —NA 1 A 2 , —COOA 1 or —CONA 1 A 2 , and A 1
  • Q represents a halogen atom, —OA 1 , —SO m A 1 where m is an integer of 0 to 3, or —NA 1 A 2
  • R represents a hydrocarbon group having 1 to 12 carbon atoms
  • X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —C n F 2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA 1 , —SO m A 1 where m is an integer of 0 to 3, —NA 1 A 2 , —COOA 1 or —CONA 1 A 2
  • Z represents CW or N
  • W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —C n F 2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA 1 ,
  • a novel fluorine-containing pyrimidine compound having substituents at the 4-position and 6-position of the pyrimidine ring, and a thiophene ring structure or a thiazole ring structure as a thiophene-based substituent at the 2-position, and a production method capable of easily producing the fluorine-containing pyrimidine compound, can be provided.
  • R represents a hydrocarbon group having 1 to 12 carbon atoms
  • X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —C n F 2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA 1 , —SO m A 1 (m is an integer of 0 to 3), —NA 1 A 2 , —COOA 1 or —CONA 1 A 2
  • Z represents CW or N
  • W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —C n F 2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA 1 , —SO m A 1 (m is an integer of 0 to 3), —NA 1 A 2 , —COOA 1 or —CONA
  • R is not particularly limited as long as it is a hydrocarbon group having 1 to 12 carbon atoms and is composed of a carbon atom and a hydrogen atom, and includes a chain hydrocarbon group, an aromatic hydrocarbon group, an alicyclic hydrocarbon group and the like.
  • the chain hydrocarbon group is not particularly limited as long as the total number of carbon atoms is 1 to 12, and may be a linear hydrocarbon group or a branched chain hydrocarbon group.
  • R is an aromatic hydrocarbon group
  • the aromatic hydrocarbon group is not particularly limited as long as the total number of carbon atoms is 6 to 12, and may be an aromatic hydrocarbon group having a substituent or an aromatic hydrocarbon group having no substituent.
  • the aromatic hydrocarbon group may have a condensed polycyclic structure.
  • R is an alicyclic hydrocarbon group
  • the alicyclic hydrocarbon group is not particularly limited as long as the total number of carbon atoms is 3 to 12, and may be an alicyclic hydrocarbon group having a substituent or an alicyclic hydrocarbon group having no substituent. Further, the alicyclic hydrocarbon group may have a bridged ring structure.
  • Examples of the chain hydrocarbon group include alkyl groups such as a methyl group, an ethyl group, a n-propyl group, an i-propyl group, a n-butyl group, an i-butyl group, a sec-butyl group, a ter-butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a nonyl group, a decyl group, an undecyl group and a dodecyl group;
  • Examples of the alicyclic hydrocarbon group include a saturated or unsaturated cyclic hydrocarbon group, and examples of the cyclic hydrocarbon group include a cyclopropyl group, a cyclobutyl group, a cyclohexyl group, a cyclopentyl group, an adamantyl group and a norbornyl group.
  • R is preferably an alkyl group having 1 to 10 carbon atoms.
  • R being an alkyl group having 1 to 10 carbon atoms enables the fluoroisobutylene derivative of formula (4) and the fluoroisobutane derivative of formula (8), which are raw materials of the fluorine-containing pyrimidine compound, to be easily prepared.
  • X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —C n F 2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA 1 , —SO m A 1 (m is an integer of 0 to 3), —NA 1 A 2 , —COOA 1 or —CONA 1 A 2 , and each preferably represent a hydrogen atom, a halogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
  • X and Y may be the same or different from each other.
  • the halogen atom is F, Cl, Br or I, and preferably F or Cl.
  • a 1 included in —OA 1 and —SO m A 1 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
  • a 1 represents a hydrocarbon group having 1 to 10 carbon atoms, it can be, for example, a hydrocarbon group having 1 to 10 carbon atoms in R described above.
  • m is an integer of 0 to 3, preferably an integer of 0 to 2, and more preferably an integer of 0 to 1.
  • a 1 and A 2 included in —NA 1 A 2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
  • a 1 and A 2 may be the same or different from each other.
  • a 1 and A 2 represent a hydrocarbon group having 1 to 10 carbon atoms, they can be, for example, hydrocarbon groups having 1 to 10 carbon atoms in R described above.
  • a 1 included in —COOA 1 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
  • a 1 represents a hydrocarbon group having 1 to 10 carbon atoms, it can be, for example, a hydrocarbon group having 1 to 10 carbon atoms in R described above.
  • a 1 and A 2 included in —CONA 1 A 2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
  • a 1 and A 2 may be the same or different from each other.
  • a 1 and A 2 represent a hydrocarbon group having 1 to 10 carbon atoms, they can be, for example, hydrocarbon groups having 1 to 10 carbon atoms in R described above.
  • Z represents CW or N.
  • W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —C n F 2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA 1 , —SO m A 1 (m is an integer of 0 to 3), —NA 1 A 2 , —COOA 1 or —CONA 1 A 2 , and preferably represents a hydrogen atom, a halogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
  • the halogen atom is F, Cl, Br or I, and preferably F or Cl.
  • a 1 included in —OA 1 and —SO m A 1 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
  • a 1 represents a hydrocarbon group having 1 to 10 carbon atoms, it can be, for example, a hydrocarbon group having 1 to 10 carbon atoms in R described above.
  • m is an integer of 0 to 3, preferably an integer of 0 to 2, and more preferably an integer of 0 to 1.
  • a 1 included in —COOA 1 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
  • a 1 represents a hydrocarbon group having 1 to 10 carbon atoms, it can be, for example, a hydrocarbon group having 1 to 10 carbon atoms in R described above.
  • a 1 and A 2 included in —CONA 1 A 2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
  • a 1 and A 2 may be the same or different from each other.
  • a 1 and A 2 represent a hydrocarbon group having 1 to 10 carbon atoms, they can be, for example, hydrocarbon groups having 1 to 10 carbon atoms in R described above.
  • the fluorine-containing pyrimidine compound in one embodiment has a specific substituent (thiophene group or thiazole group) at the 2-position of the pyrimidine ring, and specific substituents (—OR, —CF 3 and —F) at the 4-position, 5-position and 6-position of the pyrimidine ring, and thereby it can have an excellent effect from the viewpoint of structural expandability.
  • desired biological activity for example, growth inhibitory activity on various viruses, antibacterial activity against various bacteria, antitumor activity
  • control activity on pathogens of rice blast and the like can be expected.
  • the thiophene ring structure or thiazole ring structure located on the 2-position of the pyrimidine ring may or may not have a substituent.
  • the thiophene ring structure or the thiazole ring structure having a substituent can further impart properties to the fluorine-containing pyrimidine compound in one embodiment.
  • the substituents on the 4- and 6-positions of the pyrimidine ring being different groups (—OR and —F) can facilitate derivatization into an asymmetric structure, which can also be expected to be used as an intermediate. More specifically, reacting the fluorine-containing pyrimidine compound under acidic conditions to modify —OR can provide a derivative.
  • reacting the fluorine-containing pyrimidine compound under basic conditions to modify —F can provide a derivative.
  • the fluorine-containing pyrimidine compound in one embodiment is useful in the field of, for example, electronic materials such as organic semiconductors and liquid crystals.
  • R is the same as that defined in the compounds of formulae (1) to (3) described above
  • each of X, Y and Z is the same as that defined in the compounds of formulae (1) to (3) described above.
  • Z is CW, as described above, when W and X are adjacent to each other, W and X may be bonded to each other to form a ring together with the carbon atoms to which they are bonded, and when W and Y are adjacent to each other, W and Y may be bonded to each other to form a ring together with the carbon atoms to which they are bonded.
  • R in the above formulae (1) to (4) preferably represents an alkyl group having 1 to 10 carbon atoms.
  • R in formula (4) can be, for example, an alkyl group having 1 to 10 carbon atoms in R in formulae (1) to (3) described above.
  • reaction formula (A) A reaction of (a) above between the fluoroisobutylene derivative represented by formula (4) and the compound represented by formula (5) is represented by the following reaction formula (A).
  • reaction formula (B) A reaction of (b) above between the fluoroisobutylene derivative represented by formula (4) and the compound represented by formula (6) is represented by the following reaction formula (B).
  • reaction formula (C) A reaction of (c) above between the fluoroisobutylene derivative represented by formula (4) and the compound represented by formula (7) is represented by the following reaction formula (C).
  • the reactions of (a) to (c) above can be carried out in one step in the presence of a hydrogen halide scavenger. Therefore, the fluorine-containing pyrimidine compounds of the above formulae (1) to (3) can be easily obtained.
  • a cyclic pyrimidine structure is formed between the fluoroisobutylene derivative represented by formula (4) and the amidino group of the compounds of formulae (5) to (7).
  • a group derived from the thiophene ring structure or the thiazole ring structure of the compounds of formulae (5) to (7) is located.
  • —OR, CF 3 and F derived from the fluoroisobutylene derivative are located at the 4-position, 5-position and 6-position of the pyrimidine structure, respectively.
  • the hydrogen halide scavenger is a substance having a function of capturing hydrogen fluoride (HF) formed from a hydrogen atom derived from the amidino group in the compounds of formulae (5) to (7) and a fluorine atom derived from the fluoroisobutylene derivative of formula (4), in the reaction formulae (A) to (C).
  • HF hydrogen fluoride
  • an inorganic compound such as sodium hydroxide, potassium hydroxide, calcium hydroxide, sodium carbonate, potassium carbonate, sodium fluoride and potassium fluoride, and an organic nitrogen derivative such as pyridine, triethylamine, diisopropylethylamine, diazabicyclononene, diazabicycloundecene, methyltriazabicyclodecene and diazabicyclooctane, can be used.
  • a reaction temperature upon reactions (a) to (c) above is preferably 0 to 100° C., more preferably 5 to 50° C., and still more preferably 10 to 20° C.
  • a reaction time upon reactions (a) to (c) above is preferably 0.5 to 48 hours, more preferably 1 to 36 hours, and still more preferably 2 to 12 hours.
  • a solvent used in the reactions of (a) to (c) above includes aprotic polar solvents such as tetrahydrofuran, monoglyme, diglyme, triglyme, tetraglyme, acetonitrile, dimethylformamide, dimethylacetamide, methylpyrrolidone, dimethylethyleneurea, tetramethylurea, dimethylsulfoxide and sulfolane, or two-phase solvents of a protonic polar solvent such as water and a water-insoluble solvent such as dichloromethane, toluene and diethyl ether.
  • aprotic polar solvents such as tetrahydrofuran, monoglyme, diglyme, triglyme, tetraglyme, acetonitrile, dimethylformamide, dimethylacetamide, methylpyrrolidone, dimethylethyleneurea, tetramethylurea, dimethylsulfoxide and sulfolane,
  • quaternary ammonium halides such as benzyltriethylammonium chloride, a quaternary phosphonium halide and crown ether can be used.
  • Q represents a halogen atom, —OA 1 , —SO m A 1 (m is an integer of 0 to 3) or —NA 1 A 2
  • R represents a hydrocarbon group having 1 to 12 carbon atoms
  • X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —C n F 2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA 1 , —SO m A 1 (m is an integer of 0 to 3), —NA 1 A 2 , —COOA 1 or —CONA 1 A 2
  • Z represents CW or N
  • W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —C n F 2n+1 (n is an integer of 1 to 10), a nitro group,
  • R in the above formulae (1) to (3) and (8) preferably represents an alkyl group having 1 to 10 carbon atoms.
  • R in formula (8) can be, for example, an alkyl group having 1 to 10 carbon atoms in R in formulae (1) to (3) described above.
  • reaction formula (E) A reaction of (e) above between the fluoroisobutane derivative represented by formula (8) and the compound represented by formula (6) is represented by the following reaction formula (E).
  • reaction formula (F) A reaction of (f) above between the fluoroisobutane derivative represented by formula (8) and the compound represented by formula (7) is represented by the following reaction formula (F).
  • a reaction temperature upon reactions (d) to (f) above is preferably 0 to 100° C., more preferably 5 to 50° C., and still more preferably 10 to 20° C.
  • a reaction time upon reactions (d) to (f) above is preferably 0.5 to 48 hours, more preferably 1 to 36 hours, and still more preferably 4 to 24 hours.
  • the same hydrogen halide scavengers as those of (a) to (c) above may be used.
  • a solvent used in the reactions of (d) to (f) above includes aprotic polar solvents such as tetrahydrofuran, monoglyme, diglyme, triglyme, tetraglyme, acetonitrile, dimethylformamide, dimethylacetamide, methylpyrrolidone, dimethylethyleneurea, tetramethylurea, dimethylsulfoxide and sulfolane, or two-phase solvents of a protonic polar solvent such as water and a water-insoluble solvent such as dichloromethane, toluene and diethyl ether.
  • aprotic polar solvents such as tetrahydrofuran, monoglyme, diglyme, triglyme, tetraglyme, acetonitrile, dimethylformamide, dimethylacetamide, methylpyrrolidone, dimethylethyleneurea, tetramethylurea, dimethylsulfoxide and sulfolane,
  • quaternary ammonium halides such as benzyltriethylammonium chloride, a quaternary phosphonium halide and crown ether can be used.
  • room temperature denotes a temperature within the range of 20° C. ⁇ 5° C. unless otherwise specified.
  • Examples 4 to 6 the yields of the obtained compounds were not calculated, but types and amounts of impurities are expected to be increased due to by-products that can be generated in the course of producing 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene from 1,1,1,3,3-pentafluoro-3-methoxy-2-trifluoromethyl-propane in the reaction system. Therefore, the production methods of Examples 1, 2 and 3 are conjectured to give high yields of the obtained products as compared with the corresponding production methods of Examples 4, 5 and 6.
  • 6-fluoro-4-methoxy-2-(2-thiazolyl)-5-(trifluoromethyl)pyrimidine prepared in Example 3 was dissolved in acetone to prepare a solution having a concentration of 100,000 ppm. Next, to 1 ml of this acetone solution was added sterilized water to make 50 ml to prepare a test solution having a concentration of 2,000 ppm. Further, to 10 ml of a separately prepared test solution having a concentration of 2,000 ppm was added sterilized water to make 20 ml to prepare a test solution having a concentration of 1,000 ppm.
  • without treatment means that 1 ml of acetone was diluted with sterilized water to 50 ml as a test solution, and the solution was added dropwise to the culture medium.
  • with treatment means that a test solution that had been diluted and adjusted to a set concentration was added dropwise to the culture medium.
  • the fluorine-containing pyrimidine compound of the present disclosure exhibits the control activity against the pathogens of rice blast, and is found to be effective as a compound exhibiting a biological activity.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fishing Rods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A fluorine-containing pyrimidine compound represented by formula (1), (2) or (3) is provided:
Figure US12435076-20251007-C00001
wherein in formulae (1) to (3), R represents a hydrocarbon group having 1 to 12 carbon atoms, X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1, a nitro group, a boronic acid group, -OA1, —SOmA1, -NA1A2, —COOA1 or —CONA1A2, Z represents CW or N, W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1, a nitro group, a boronic acid group, —OA1, —SOmA1, —NA1A2, —COOA1 or —CONA1A2, n is an integer of 1 to 10 and m is an integer of 0 to 3, and A1 and A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.

Description

CROSS REFERENCE TO RELATED APPLICATIONS
This is the National Stage of International Application No. PCT/JP2020/040682, filed Oct. 29, 2020, which claims the benefit of Japanese Patent Application No. 2019-200237 filed Nov. 1, 2019.
BACKGROUND Technical Field
The present disclosure relates to a fluorine-containing pyrimidine compound and a method for producing the same.
Related Art
Conventionally, fluorine-containing pyrimidine compounds have been reported to have various biological activities. Among them, a compound having a thiophene ring or a thiazole ring as a substituent at the 2-position of the pyrimidine ring is expected to be used in the fields of medicine and agrochemicals.
More specifically, International Publication No. WO 2011/019405, International Publication No. WO 2013/086131, and International Publication No. WO 2009/129905 disclose a compound having a thiophene ring at the 2-position of a pyrimidine ring. International Publication No. WO 2011/019405 reports that a compound having a 2-(2-thienyl)-5-(trifluoromethyl)pyrimidine structure has a tubercle bacillus growth inhibitory activity. International Publication No. WO 2013/086131 reports that a compound having a 2-(2-thienyl)-pyrimidine structure has a growth inhibitory activity on influenza A virus having drug resistance. In International Publication No. WO 2009/129905, a compound having a 2-(3-thienyl)-pyrimidine structure is synthesized as an antitumor active compound.
Moreover, International Publication No. WO 2012/027236, International Publication No. WO 2016/196644, and International Publication No. WO 2017/139603 disclose a compound having a thiazole ring at the 2-position of a pyrimidine ring. International Publication No. WO 2012/027236 reports that a compound having a 2-(2-thiazolyl)-pyrimidine structure has an antitumor activity against prostate tumors and the like. International Publication No. WO 2016/196644 reports that a compound having a 2-(4-thiazolyl)-5-(trifluoromethyl)pyrimidine structure has an antitumor activity against Burkitt lymphoma. International Publication No. WO 2017/139603 reports that a compound having a 2-(5-thiazolyl)-pyrimidine structure is effective for a treatment of hypertension, PTSD, depression, pain and the like. From such viewpoints, introduction of substituents to the 4- and 6-positions of the pyrimidine ring has drawn attention in anticipation of further improvement in the activity.
Tetrahedron, Vol. 72, 2016, pp. 3250-3255, ACS Catalysis, Vol. 8, 2018, pp. 2839-2843, and Angewandte Chemie International Edition, Vol. 57, 2018, pp. 6926-6929 disclose, on the other hand, a method for synthesizing a pyrimidine compound having a trifluoromethyl group at the 5-position of a pyrimidine ring and substituents at the 4-position and the 6-position. More specifically, Tetrahedron, Vol. 72, 2016, pp. 3250-3255 reports a synthetic method using sodium trifluoromethanesulfinate (Langlois reagent), ACS Catalysis, Vol. 8, 2018, pp. 2839-2843 reports a synthetic method using a trifluoroacetic acid derivative, and Angewandte Chemie International Edition, Vol. 57, 2018, pp. 6926-6929 reports a synthetic method using trifluoromethanesulfonic acid anhydride.
Technical Problem
However, from the viewpoint of reactivity and selectivity, conventionally, it has been difficult to produce a fluorine-containing pyrimidine compound having a fluorine-containing substituent at the 5-position of the pyrimidine ring, a heterocyclic ring as a substituent at the 2-position, and substituents at the 4-position and the 6-position, and such a fluorine-containing pyrimidine compound has not been reported. The fluorine-containing pyrimidine compound is expected to have various biological activities, and a novel fluorine-containing pyrimidine compound having substituents at the 4- and 6-positions of a pyrimidine ring and a heterocyclic ring as a substituent at the 2-position, and establishment of a production method therefor, have been desired.
In the production method reported in Tetrahedron, Vol. 72, 2016, pp. 3250-3255, the regioselectivity upon introduction of a trifluoromethyl group is low, which thereby raises a concern of decreasing introduction efficiency of trifluoromethyl group for a substrate having a plurality of heterocyclic rings such as a pyrimidine compound substituted with a heterocyclic ring, or a concern of difficulty in introducing a trifluoromethyl group. Moreover, there have been problems such as not only using 3 times an amount of Langlois reagent as a trifluoromethylating agent with respect to the substrate but also using manganese acetate (III) hydrate that is harmful as an oxidizing agent in an amount 3 times that of the substrate.
It is considered that by further modification and derivatization of the compound obtained by the production methods reported in ACS Catalysis, Vol. 8, 2018, pp. 2839-2843, and Angewandte Chemie International Edition, Vol. 57, 2018, pp. 6926-6929, it is converted into the fluorine-containing pyrimidine compound. However, there have been cases where complexity and reduction in efficiency due to an increase in the number of steps are unavoidable, or the production of the fluorine-containing pyrimidine compound itself is difficult. Further, it is considered to be unsuitable for practical use because irradiation with light in the presence of a ruthenium complex catalyst is necessary, 2.5 to 3 times an amount of trifluoromethylating agent is required for use with respect to the substrate in ACS Catalysis, Vol. 8, 2018, pp. 2839-2843, and Angewandte Chemie International Edition, Vol. 57, 2018, pp. 6926-6929 times an amount of trifluoromethylating agent is required for use with respect to the substrate in Angewandte Chemie International Edition, Vol. 57, 2018, pp. 6926-6929.
Therefore, the present inventors have found that a thiophene ring structure or a thiazole ring structure can be introduced at the 2-position between the two nitrogen atoms on a pyrimidine ring by reacting a specific raw material, and thus have completed the present disclosure. Namely, it is an object of the present disclosure to provide a novel fluorine-containing pyrimidine compound that has substituents at the 4-position and the 6-position of the pyrimidine ring and a thiophene ring structure or a thiazole ring structure as a substituent at the 2-position, which has not been known conventionally, and a production method capable of easily producing the fluorine-containing pyrimidine compound.
SUMMARY
The configuration of the present disclosure is as follows.
[1] An aspect of the present disclosure is a fluorine-containing pyrimidine compound represented by the following formula (1), (2) or (3):
Figure US12435076-20251007-C00002
wherein
R represents a hydrocarbon group having 1 to 12 carbon atoms,
X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA1, —SOmA1 where m is an integer of 0 to 3, —NA1A2, —COOA1 or —CONA1A2,
Z represents CW or N,
W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA1, —SOmA1 where m is an integer of 0 to 3, —NA1A2, —COOA1 or —CONA1A2, and
A1 and A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
[2] In the aspect of the present disclosure, R is an alkyl group having 1 to 10 carbon atoms.
[3] Another aspect of the present disclosure is a method for producing a fluorine-containing pyrimidine compound, including:
(a) a step of reacting a fluoroisobutylene derivative represented by the following formula (4) with a compound represented by the following formula (5) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (1):
Figure US12435076-20251007-C00003
(b) a step of reacting a fluoroisobutylene derivative represented by the following formula (4) with a compound represented by the following formula (6) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (2):
Figure US12435076-20251007-C00004
or
(c) a step of reacting a fluoroisobutylene derivative represented by the following formula (4) with a compound represented by the following formula (7) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (3):
Figure US12435076-20251007-C00005
wherein
R represents a hydrocarbon group having 1 to 12 carbon atoms,
X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA1, —SOmA1 where m is an integer of 0 to 3, —NA1A2, —COOA1 or —CONA1A2,
Z represents CW or N,
W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA1, —SOmA1 where m is an integer of 0 to 3, —NA1A2, —COOA1 or —CONA1A2, and
A1 and A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
[4] Another aspect of the present disclosure is a method for producing a fluorine-containing pyrimidine compound, including:
(d) a step of reacting a fluoroisobutane derivative represented by the following formula (8) with a compound represented by the following formula (5) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (1):
Figure US12435076-20251007-C00006
(e) a step of reacting a fluoroisobutane derivative represented by the following formula (8) with a compound represented by the following formula (6) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (2):
Figure US12435076-20251007-C00007
or
(f) a step of reacting a fluoroisobutane derivative represented by the following formula (8) with a compound represented by the following formula (7) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (3):
Figure US12435076-20251007-C00008
wherein
Q represents a halogen atom, —OA1, —SOmA1 where m is an integer of 0 to 3, or —NA1A2,
R represents a hydrocarbon group having 1 to 12 carbon atoms,
X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA1, —SOmA1 where m is an integer of 0 to 3, —NA1A2, —COOA1 or —CONA1A2,
Z represents CW or N,
W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA1, —SOmA1 where m is an integer of 0 to 3, —NA1A2, —COOA1 or —CONA1A2, and
A1 and A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
[5] In the aspect of the present disclosure according to the method for producing a fluorine-containing pyrimidine compound, R is an alkyl group having 1 to 10 carbon atoms.
Effects of Invention
A novel fluorine-containing pyrimidine compound having substituents at the 4-position and 6-position of the pyrimidine ring, and a thiophene ring structure or a thiazole ring structure as a thiophene-based substituent at the 2-position, and a production method capable of easily producing the fluorine-containing pyrimidine compound, can be provided.
DETAILED DESCRIPTION
Hereinafter, embodiments of the present disclosure will be described in detail. However, the scope of the present disclosure is not limited to the specific examples described below.
(Fluorine-Containing Pyrimidine Compound)
The fluorine-containing pyrimidine compound in one embodiment is represented by the following formula (1), (2) or (3):
Figure US12435076-20251007-C00009
wherein in the above formulae (1) to (3),
R represents a hydrocarbon group having 1 to 12 carbon atoms,
X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA1, —SOmA1 (m is an integer of 0 to 3), —NA1A2, —COOA1 or —CONA1A2,
Z represents CW or N,
W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA1, —SOmA1 (m is an integer of 0 to 3), —NA1A2, —COOA1 or —CONA1A2, and
A1 and A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
R is not particularly limited as long as it is a hydrocarbon group having 1 to 12 carbon atoms and is composed of a carbon atom and a hydrogen atom, and includes a chain hydrocarbon group, an aromatic hydrocarbon group, an alicyclic hydrocarbon group and the like. The chain hydrocarbon group is not particularly limited as long as the total number of carbon atoms is 1 to 12, and may be a linear hydrocarbon group or a branched chain hydrocarbon group. When R is an aromatic hydrocarbon group, the aromatic hydrocarbon group is not particularly limited as long as the total number of carbon atoms is 6 to 12, and may be an aromatic hydrocarbon group having a substituent or an aromatic hydrocarbon group having no substituent. Moreover, the aromatic hydrocarbon group may have a condensed polycyclic structure. When R is an alicyclic hydrocarbon group, the alicyclic hydrocarbon group is not particularly limited as long as the total number of carbon atoms is 3 to 12, and may be an alicyclic hydrocarbon group having a substituent or an alicyclic hydrocarbon group having no substituent. Further, the alicyclic hydrocarbon group may have a bridged ring structure.
Examples of the chain hydrocarbon group include alkyl groups such as a methyl group, an ethyl group, a n-propyl group, an i-propyl group, a n-butyl group, an i-butyl group, a sec-butyl group, a ter-butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a nonyl group, a decyl group, an undecyl group and a dodecyl group;
    • alkenyl groups such as an ethenyl group, a propenyl group, a butenyl group, a pentenyl group, a hexenyl group, a heptenyl group, an octenyl group, a nonenyl group, a decenyl group, an undecenyl group and a dodecenyl group; and
    • alkynyl groups such as an ethynyl group, a propynyl group, a butynyl group, a pentynyl group, a hexynyl group, a heptynyl group, an octynyl group, a nonynyl group, a decynyl group, an undecynyl group and a dodecynyl group.
Examples of the aromatic hydrocarbon group include a phenyl group and a naphthyl group.
Examples of the alicyclic hydrocarbon group include a saturated or unsaturated cyclic hydrocarbon group, and examples of the cyclic hydrocarbon group include a cyclopropyl group, a cyclobutyl group, a cyclohexyl group, a cyclopentyl group, an adamantyl group and a norbornyl group.
R is preferably an alkyl group having 1 to 10 carbon atoms. R being an alkyl group having 1 to 10 carbon atoms enables the fluoroisobutylene derivative of formula (4) and the fluoroisobutane derivative of formula (8), which are raw materials of the fluorine-containing pyrimidine compound, to be easily prepared.
X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA1, —SOmA1 (m is an integer of 0 to 3), —NA1A2, —COOA1 or —CONA1A2, and each preferably represent a hydrogen atom, a halogen atom or a hydrocarbon group having 1 to 10 carbon atoms. X and Y may be the same or different from each other.
In X and Y, the halogen atom is F, Cl, Br or I, and preferably F or Cl.
In X and Y, the hydrocarbon group having 1 to 10 carbon atoms is not particularly limited as long as it is a hydrocarbon group composed of a carbon atom and a hydrogen atom, and can be, for example, a hydrocarbon group having 1 to 10 carbon atoms in R described above.
In X and Y, —CnF2n+1 is not particularly limited as long as it is a perfluoroalkyl group composed of a carbon atom and a fluorine atom, and may be linear or branched. In addition, n is an integer of 1 to 10, and preferably an integer of 1 to 3.
In X and Y, A1 included in —OA1 and —SOmA1 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms. When A1 represents a hydrocarbon group having 1 to 10 carbon atoms, it can be, for example, a hydrocarbon group having 1 to 10 carbon atoms in R described above. Further, m is an integer of 0 to 3, preferably an integer of 0 to 2, and more preferably an integer of 0 to 1.
In X and Y, A1 and A2 included in —NA1A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms. A1 and A2 may be the same or different from each other. When A1 and A2 represent a hydrocarbon group having 1 to 10 carbon atoms, they can be, for example, hydrocarbon groups having 1 to 10 carbon atoms in R described above.
In X and Y, A1 included in —COOA1 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms. When A1 represents a hydrocarbon group having 1 to 10 carbon atoms, it can be, for example, a hydrocarbon group having 1 to 10 carbon atoms in R described above.
In X and Y, A1 and A2 included in —CONA1A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms. A1 and A2 may be the same or different from each other. When A1 and A2 represent a hydrocarbon group having 1 to 10 carbon atoms, they can be, for example, hydrocarbon groups having 1 to 10 carbon atoms in R described above.
Z represents CW or N. When Z is CW, W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA1, —SOmA1 (m is an integer of 0 to 3), —NA1A2, —COOA1 or —CONA1A2, and preferably represents a hydrogen atom, a halogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
In W, the halogen atom is F, Cl, Br or I, and preferably F or Cl.
In W, the hydrocarbon group having 1 to 10 carbon atoms is not particularly limited as long as it is a hydrocarbon group composed of a carbon atom and a hydrogen atom, and can be, for example, a hydrocarbon group having 1 to 10 carbon atoms in R described above.
In W, —CnF2n+1 is not particularly limited as long as it is a perfluoroalkyl group composed of a carbon atom and a fluorine atom, and may be linear or branched. In addition, n is an integer of 1 to 10, and preferably an integer of 1 to 3.
In W, A1 included in —OA1 and —SOmA1 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms. When A1 represents a hydrocarbon group having 1 to 10 carbon atoms, it can be, for example, a hydrocarbon group having 1 to 10 carbon atoms in R described above. Further, m is an integer of 0 to 3, preferably an integer of 0 to 2, and more preferably an integer of 0 to 1.
In W, A1 and A2 included in —NA1A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms. A1 and A2 may be the same or different from each other. When A1 and A2 represent a hydrocarbon group having 1 to 10 carbon atoms, they can be, for example, hydrocarbon groups having 1 to 10 carbon atoms in R described above.
In W, A1 included in —COOA1 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms. When A1 represents a hydrocarbon group having 1 to 10 carbon atoms, it can be, for example, a hydrocarbon group having 1 to 10 carbon atoms in R described above.
In W, A1 and A2 included in —CONA1A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms. A1 and A2 may be the same or different from each other. When A1 and A2 represent a hydrocarbon group having 1 to 10 carbon atoms, they can be, for example, hydrocarbon groups having 1 to 10 carbon atoms in R described above.
In the above formulae (1) to (3), when W and X are adjacent to each other, W and X may be bonded to each other to form a ring together with the carbon atoms to which they are bonded, and when W and Y are adjacent to each other, W and Y may be bonded to each other to form a ring together with the carbon atoms to which they are bonded. The rings thus formed may be an aromatic ring or a non-aromatic ring, and may be a carbon ring or a heterocyclic ring. When a ring is formed, the number of carbon atoms on the ring is not particularly limited, but is preferably 4 to 20, more preferably 6 to 20, and still more preferably 6 to 10. Examples of such rings include a benzothiophene ring. Among these, a benzothiazole ring is preferred.
The fluorine-containing pyrimidine compound in one embodiment has a specific substituent (thiophene group or thiazole group) at the 2-position of the pyrimidine ring, and specific substituents (—OR, —CF3 and —F) at the 4-position, 5-position and 6-position of the pyrimidine ring, and thereby it can have an excellent effect from the viewpoint of structural expandability. In particular, desired biological activity (for example, growth inhibitory activity on various viruses, antibacterial activity against various bacteria, antitumor activity) can be expected, and for example, control activity on pathogens of rice blast and the like can be expected. The thiophene ring structure or thiazole ring structure located on the 2-position of the pyrimidine ring may or may not have a substituent. The thiophene ring structure or the thiazole ring structure having a substituent can further impart properties to the fluorine-containing pyrimidine compound in one embodiment. Moreover, the substituents on the 4- and 6-positions of the pyrimidine ring being different groups (—OR and —F) can facilitate derivatization into an asymmetric structure, which can also be expected to be used as an intermediate. More specifically, reacting the fluorine-containing pyrimidine compound under acidic conditions to modify —OR can provide a derivative. Moreover, reacting the fluorine-containing pyrimidine compound under basic conditions to modify —F can provide a derivative. The fluorine-containing pyrimidine compound in one embodiment is useful in the field of, for example, electronic materials such as organic semiconductors and liquid crystals.
(Method for Producing Fluorine-Containing Pyrimidine Compound)
A method for producing a fluorine-containing pyrimidine compound in one embodiment includes:
    • (a) a step of reacting a fluoroisobutylene derivative represented by the following formula (4) with a compound represented by the following formula (5) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (1):
Figure US12435076-20251007-C00010
    • (b) a step of reacting a fluoroisobutylene derivative represented by the following formula (4) with a compound represented by the following formula (6) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (2):
Figure US12435076-20251007-C00011
or
    • (c) a step of reacting a fluoroisobutylene derivative represented by the following formula (4) with a compound represented by the following formula (7) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (3):
Figure US12435076-20251007-C00012
wherein in the above formulae (1) to (7),
R represents a hydrocarbon group having 1 to 12 carbon atoms,
X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA1, —SOmA1 (m is an integer of 0 to 3), —NA1A2, —COOA1 or —CONA1A2,
Z represents CW or N,
W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA1, —SOmA1 (m is an integer of 0 to 3), —NA1A2, —COOA1 or —CONA1A2, and
A1 and A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
In formula (4), R is the same as that defined in the compounds of formulae (1) to (3) described above, and in formulae (5) to (7), each of X, Y and Z is the same as that defined in the compounds of formulae (1) to (3) described above. Further, in formulae (5) to (7), when Z is CW, as described above, when W and X are adjacent to each other, W and X may be bonded to each other to form a ring together with the carbon atoms to which they are bonded, and when W and Y are adjacent to each other, W and Y may be bonded to each other to form a ring together with the carbon atoms to which they are bonded.
R in the above formulae (1) to (4) preferably represents an alkyl group having 1 to 10 carbon atoms. R in formula (4) can be, for example, an alkyl group having 1 to 10 carbon atoms in R in formulae (1) to (3) described above.
A reaction of (a) above between the fluoroisobutylene derivative represented by formula (4) and the compound represented by formula (5) is represented by the following reaction formula (A).
Figure US12435076-20251007-C00013
A reaction of (b) above between the fluoroisobutylene derivative represented by formula (4) and the compound represented by formula (6) is represented by the following reaction formula (B).
Figure US12435076-20251007-C00014
A reaction of (c) above between the fluoroisobutylene derivative represented by formula (4) and the compound represented by formula (7) is represented by the following reaction formula (C).
Figure US12435076-20251007-C00015
In the above reaction formulae (A) to (C), the compounds of the above formulae (5) to (7) each may be in the form of salt. Examples of the compounds of formulae (5) to (7) in the form of salts include a compound in a form of at least one of the amino moiety (—NH2) and the imino moiety (═NH) constituting the amidino group of the compounds of formulae (5) to (7), being cationized to (—NH3 +) and (═NH2 +) to form a salt with the counterion. The counterion is not particularly limited as long as it is a monovalent anion, and includes, for example, halide ions such as F−, Cl−, Br− and I−.
In the method for producing a fluorine-containing pyrimidine compound in one embodiment, for example, the reactions of (a) to (c) above can be carried out in one step in the presence of a hydrogen halide scavenger. Therefore, the fluorine-containing pyrimidine compounds of the above formulae (1) to (3) can be easily obtained. In the reactions of (a) to (c) above, a cyclic pyrimidine structure is formed between the fluoroisobutylene derivative represented by formula (4) and the amidino group of the compounds of formulae (5) to (7). At the 2-position of the pyrimidine structure, a group derived from the thiophene ring structure or the thiazole ring structure of the compounds of formulae (5) to (7) is located. Further, —OR, CF3 and F derived from the fluoroisobutylene derivative are located at the 4-position, 5-position and 6-position of the pyrimidine structure, respectively.
The hydrogen halide scavenger is a substance having a function of capturing hydrogen fluoride (HF) formed from a hydrogen atom derived from the amidino group in the compounds of formulae (5) to (7) and a fluorine atom derived from the fluoroisobutylene derivative of formula (4), in the reaction formulae (A) to (C). As the hydrogen halide scavenger, an inorganic compound such as sodium hydroxide, potassium hydroxide, calcium hydroxide, sodium carbonate, potassium carbonate, sodium fluoride and potassium fluoride, and an organic nitrogen derivative such as pyridine, triethylamine, diisopropylethylamine, diazabicyclononene, diazabicycloundecene, methyltriazabicyclodecene and diazabicyclooctane, can be used.
A reaction temperature upon reactions (a) to (c) above is preferably 0 to 100° C., more preferably 5 to 50° C., and still more preferably 10 to 20° C. A reaction time upon reactions (a) to (c) above is preferably 0.5 to 48 hours, more preferably 1 to 36 hours, and still more preferably 2 to 12 hours.
A solvent used in the reactions of (a) to (c) above includes aprotic polar solvents such as tetrahydrofuran, monoglyme, diglyme, triglyme, tetraglyme, acetonitrile, dimethylformamide, dimethylacetamide, methylpyrrolidone, dimethylethyleneurea, tetramethylurea, dimethylsulfoxide and sulfolane, or two-phase solvents of a protonic polar solvent such as water and a water-insoluble solvent such as dichloromethane, toluene and diethyl ether. Moreover, as a catalyst for the reactions of (a) to (c) above, quaternary ammonium halides such as benzyltriethylammonium chloride, a quaternary phosphonium halide and crown ether can be used.
A method for producing a fluorine-containing pyrimidine compound of another embodiment includes:
    • (d) a step of reacting a fluoroisobutane derivative represented by the following formula (8) with a compound represented by the following formula (5) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (1):
Figure US12435076-20251007-C00016
    • (e) a step of reacting a fluoroisobutane derivative represented by the following formula (8) with a compound represented by the following formula (6) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (2):
Figure US12435076-20251007-C00017
or
    • (f) a step of reacting a fluoroisobutane derivative represented by the following formula (8) with a compound represented by the following formula (7) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (3):
Figure US12435076-20251007-C00018
wherein in the above formulae (1) to (3) and (5) to (8),
Q represents a halogen atom, —OA1, —SOmA1 (m is an integer of 0 to 3) or —NA1A2,
R represents a hydrocarbon group having 1 to 12 carbon atoms,
X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA1, —SOmA1 (m is an integer of 0 to 3), —NA1A2, —COOA1 or —CONA1A2,
Z represents CW or N,
W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 (n is an integer of 1 to 10), a nitro group, a boronic acid group, —OA1, —SOmA1 (m is an integer of 0 to 3), —NA1A2, —COOA1 or —CONA1A2, and
A1 and A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
In formula (8), R is the same as that defined in the compounds of formulae (1) to (3) described above, and the halogen atom, —OA1, —SOmA1 (m is an integer of 0 to 3) and —NA1A2 are the same as those defined in the compounds of formulae (1) to (3) described above.
R in the above formulae (1) to (3) and (8) preferably represents an alkyl group having 1 to 10 carbon atoms. R in formula (8) can be, for example, an alkyl group having 1 to 10 carbon atoms in R in formulae (1) to (3) described above.
A reaction of (d) above between the fluoroisobutane derivative represented by formula (8) and the compound represented by formula (5) is represented by the following reaction formula (D).
Figure US12435076-20251007-C00019
A reaction of (e) above between the fluoroisobutane derivative represented by formula (8) and the compound represented by formula (6) is represented by the following reaction formula (E).
Figure US12435076-20251007-C00020
A reaction of (f) above between the fluoroisobutane derivative represented by formula (8) and the compound represented by formula (7) is represented by the following reaction formula (F).
Figure US12435076-20251007-C00021
In the reaction formulae (D) to (F), the compounds of formulae (5) to (7) each may be in the form of salts. Examples of the compounds of formulae (5) to (7) in the form of salts include a compound in the form of at least one of the amino moiety (—NH2) and the imino moiety (═NH) constituting the amidino group of the compounds of formulae (5) to (7), being cationized to (—NH3 +) and (═NH2 +) to form a salt with the counterion. The counterion is not particularly limited as long as it is a monovalent anion, and includes, for example, halide ions such as F−, Cl−, Br− and I−.
In the method for producing a fluorine-containing pyrimidine compound in the other embodiment, for example, the reactions of (D) to (F) above can be carried out in one step. Therefore, the fluorine-containing pyrimidine compounds of the above formulae (1) to (3) can be easily obtained. In the reactions of (d) to (f) above, a cyclic pyrimidine structure is formed between the fluoroisobutane derivative represented by formula (8) and the amidino group of the compounds of formulae (5) to (7). At the 2-position of the pyrimidine structure, a group derived from the thiophene ring structure or the thiazole ring structure of the compounds of formulae (5) to (7) is located. Further, —OR, CF3 and F derived from the fluoroisobutane derivative are located at the 4-position, 5-position and 6-position of the pyrimidine structure, respectively.
A reaction temperature upon reactions (d) to (f) above is preferably 0 to 100° C., more preferably 5 to 50° C., and still more preferably 10 to 20° C. A reaction time upon reactions (d) to (f) above is preferably 0.5 to 48 hours, more preferably 1 to 36 hours, and still more preferably 4 to 24 hours. In the reactions of (d) to (f) above, the same hydrogen halide scavengers as those of (a) to (c) above may be used.
A solvent used in the reactions of (d) to (f) above includes aprotic polar solvents such as tetrahydrofuran, monoglyme, diglyme, triglyme, tetraglyme, acetonitrile, dimethylformamide, dimethylacetamide, methylpyrrolidone, dimethylethyleneurea, tetramethylurea, dimethylsulfoxide and sulfolane, or two-phase solvents of a protonic polar solvent such as water and a water-insoluble solvent such as dichloromethane, toluene and diethyl ether. Moreover, as a catalyst for the reactions of (d) to (f) above, quaternary ammonium halides such as benzyltriethylammonium chloride, a quaternary phosphonium halide and crown ether can be used.
Although the embodiments of the present disclosure have been described above, the present disclosure is not limited to the aforementioned embodiments, and includes all aspects included in the concept and claims of the present disclosure, and can be variously modified within the scope of the present disclosure.
EXAMPLES
Hereinafter, Examples of the present disclosure will be described, but the present disclosure is not limited to these Examples as long as the gist of the present disclosure is not exceeded. Moreover, room temperature denotes a temperature within the range of 20° C.±5° C. unless otherwise specified.
Example 1
Production of 6-fluoro-4-methoxy-2-(2-thienyl)-5-(trifluoromethyl)pyrimidine
Under ice-water cooling, to 25 g of dichloromethane and 25 g of water were added 10 g (61 mmol) of 2-amidinothiophene hydrochloride and 13 g (61 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene. Subsequently, 50 ml (0.24 mol) of a 5 N sodium hydroxide aqueous solution was added dropwise such that the internal temperature did not exceed 10° C., and the temperature was raised to room temperature. After about 16 hours, the organic phase was fractionated, and then dichloromethane was distilled off under reduced pressure, and thereafter the residue was dissolved in ethyl acetate followed by column purification to obtain 4.6 g of the compound represented by the following formula (9) (chemical formula: C10H6F4N2OS, molecular weight: 278.22 g/mol). The isolated yield of the obtained compound was 14%.
Figure US12435076-20251007-C00022
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 278 ([M]+)
1H-NMR (300 MHz, CDCl3) δ ppm: 8.05 (d, 1H), 7.59 (d, 1H), 7.15 (dd, 1H), 4.18 (s, 3H)
19F-NMR (300 MHz, C6F6) δ ppm: −58.26 (d, 3F), −61.72 (dd, 1F)
Example 2
Production of 6-fluoro-4-methoxy-2-(3-thienyl)-5-(trifluoromethyl)pyrimidine
Under ice-water cooling, to 25 g of dichloromethane and 25 g of water were added 10 g (61 mmol) of 3-amidinothiophene hydrochloride and 13 g (61 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene. Subsequently, 50 ml (0.24 mol) of a 5 N sodium hydroxide aqueous solution was added dropwise such that the internal temperature did not exceed 10° C., and the temperature was raised to room temperature. After about 16 hours, the organic phase was fractionated, and then dichloromethane was distilled off under reduced pressure, and thereafter the residue was dissolved in ethyl acetate followed by column purification to obtain 2.0 g of the compound represented by the following formula (10) (chemical formula: C10H6F4N2OS, molecular weight: 278.22 g/mol). The isolated yield of the obtained compound was 58%.
Figure US12435076-20251007-C00023
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 278 ([M]+)
1H-NMR (300 MHz, CDCl3) δ ppm: 8.40 (d, 1H), 7.84 (d, 1H), 7.39 (dd, 1H), 4.20 (s, 3H)
19F-NMR (300 MHz, C6F6) δ ppm: −58.40 (d, 3F), −61.79 (dd, 1F)
Example 3
Production of 6-fluoro-4-methoxy-2-(2-thiazolyl)-5-(trifluoromethyl)pyrimidine
Under ice-water cooling, to 50 g of dichloromethane and 50 g of water were added 5 g (31 mmol) of 2-amidinothiazole hydrochloride and 4 g (18 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene. Subsequently, 15 ml (72 mmol) of a 5 N sodium hydroxide aqueous solution was added dropwise such that the internal temperature did not exceed 10° C., and the temperature was raised to room temperature. After about 16 hours, the organic phase was fractionated, and then dichloromethane was distilled off under reduced pressure, and thereafter the residue was dissolved in ethyl acetate followed by column purification to obtain 0.6 g of the compound represented by the following formula (11) (chemical formula: C9H5F4N3OS, molecular weight: 279.21 g/mol). The isolated yield of the obtained compound was 7%.
Figure US12435076-20251007-C00024
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 279 ([M]+)
1H-NMR (300 MHz, CDCl3) δ ppm: 8.12 (d, 1H), 7.67 (d, 1H), 4.28 (s, 3H)
19F-NMR (300 MHz, C6F6) δ ppm: −58.75 (d, 3F), −59.83 (dd, 1F)
Example 4
Production of 6-fluoro-4-methoxy-2-(2-thienyl)-5-(trifluoromethyl)pyrimidine by using 1,1,1,3,3-pentafluoro-3-methoxy-2-(trifluoromethyl)-propane instead of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene of Example 1
Under ice-water cooling, to 25 g of dichloromethane and 25 g of water were added 10 g (61 mmol) of 2-amidinothiophene hydrochloride and 14 g (61 mmol) of 1,1,1,3,3-pentafluoro-3-methoxy-2-(trifluoromethyl)-propane. Subsequently, 65 ml (0.31 mol) of a 5 N sodium hydroxide aqueous solution was added dropwise such that the internal temperature did not exceed 10° C., and the temperature was raised to room temperature. After about 16 hours, the organic phase was fractionated, and then dichloromethane was distilled off under reduced pressure, and thereafter the residue was dissolved in ethyl acetate followed by column purification. The analysis results of the obtained compound were the same as those of the product of Example 1.
Example 5
Production of 6-fluoro-4-methoxy-2-(3-thienyl)-5-(trifluoromethyl)pyrimidine by using 1,1,1,3,3-pentafluoro-3-methoxy-2-(trifluoromethyl)-propane instead of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene of Example 2
Under ice-water cooling, to 25 g of dichloromethane and 25 g of water were added 10 g (61 mmol) of 3-amidinothiophene hydrochloride and 14 g (61 mmol) of 1,1,1,3,3-pentafluoro-3-methoxy-2-(trifluoromethyl)-propane. Subsequently, 65 ml (0.31 mol) of a 5 N sodium hydroxide aqueous solution was added dropwise such that the internal temperature did not exceed 10° C., and the temperature was raised to room temperature. After about 16 hours, the organic phase was fractionated, and then dichloromethane was distilled off under reduced pressure, and thereafter the residue was dissolved in ethyl acetate followed by column purification. The analysis results of the obtained compound were the same as those of the product of Example 2.
Example 6
Production of 6-fluoro-4-methoxy-2-(2-thiazolyl)-5-(trifluoromethyl)pyrimidine by using 1,1,1,3,3-pentafluoro-3-methoxy-2-(trifluoromethyl)-propane instead of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene of Example 3
Under ice-water cooling, to 50 g of dichloromethane and 50 g of water were added 5 g (31 mmol) of 2-amidinothiazole hydrochloride and 4 g (18 mmol) of 1,1,1,3,3-pentafluoro-3-methoxy-2-(trifluoromethyl)-propane. Subsequently, 19 ml (90 mmol) of a 5 N sodium hydroxide aqueous solution was added dropwise such that the internal temperature did not exceed 10° C., and the temperature was raised to room temperature. After about 16 hours, the organic phase was fractionated, and then dichloromethane was distilled off under reduced pressure, and thereafter the residue was dissolved in ethyl acetate followed by column purification. The analysis results of the obtained compound were the same as those of the product of Example 3.
In Examples 4 to 6, the yields of the obtained compounds were not calculated, but types and amounts of impurities are expected to be increased due to by-products that can be generated in the course of producing 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene from 1,1,1,3,3-pentafluoro-3-methoxy-2-trifluoromethyl-propane in the reaction system. Therefore, the production methods of Examples 1, 2 and 3 are conjectured to give high yields of the obtained products as compared with the corresponding production methods of Examples 4, 5 and 6.
Example 7
Production of 6-fluoro-4-methoxy-2-(5-thiazolyl)-5-(trifluoromethyl)pyrimidine
0.7 g (4.3 mmol) of 5-amidinothiazole hydrochloride was dissolved in 45 ml of acetonitrile, to this were added 1.1 g (5.2 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 2.9 g (22.4 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 22.5 hours. After stirring, the reaction solution was purified by a column to obtain 0.5 g (1.7 mmol) of the compound represented by the following formula (12). The isolated yield of the obtained compound was 39.2%.
Figure US12435076-20251007-C00025
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 279.7 ([M+H]+)
1H-NMR (400 MHz, CDCl3) δ ppm: 8.98 (s, 1H), 8.78 (s, 1H), 4.21 (s, 3H)
Example 8
Production of 6-fluoro-4-methoxy-2-(4-thiazolyl)-5-(trifluoromethyl)pyrimidine
0.5 g (3.1 mmol) of 4-amidinothiazole hydrochloride was dissolved in 30 ml of acetonitrile, to this were added 0.8 g (3.8 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 2.1 g (16.2 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 17 hours. After stirring, the reaction solution was purified by a column to obtain 0.5 g (1.8 mmol) of the compound represented by the following formula (13). The isolated yield of the obtained compound was 58.5%.
Figure US12435076-20251007-C00026
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 279.4 ([M+H]+)
1H NMR (400 MHz, CDCl3) δ ppm: 8.97 (d, J=2.1 Hz, 1H), 8.51 (d, J=2.1 Hz, 1H), 4.26 (s, 3H)
Example 9
Production of 6-fluoro-2-(5-fluoro-2-thienyl)-4-methoxy-5-(trifluoromethyl)pyrimidine
0.6 g (3.4 mmol) of 5-fluoro-2-amidinothiophene hydrochloride was dissolved in 35 ml of acetonitrile, to this were added 0.8 g (3.8 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 2.3 g (17.8 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 22 hours. After stirring, the reaction solution was purified by a column to obtain 0.6 g (2.1 mmol) of the compound represented by the following formula (14). The isolated yield of the obtained compound was 61.2%.
Figure US12435076-20251007-C00027
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 295.6 ([M+H]+)
1H NMR (400 MHz, CDCl3) δ ppm: 7.77 (dd, J=4.4, 3.8 Hz, 1H), 6.59 (dd, J=4.3, 1.5 Hz, 1H), 4.16 (s, 3H)
Example 10
Production of 2-(5-chloro-2-thienyl)-6-fluoro-4-methoxy-5-(trifluoromethyl)pyrimidine
0.5 g (2.6 mmol) of 5-chlorothiophene-2-carboxyimideamide hydrochloride was dissolved in 25 ml of acetonitrile, to this were added 0.7 g (3.3 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.7 g (13.2 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 28 hours. After stirring, the reaction solution was purified by a column to obtain 0.3 g (1.1 mmol) of the compound represented by the following formula (15). The isolated yield of the obtained compound was 41.9%.
Figure US12435076-20251007-C00028
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 312.0 ([M+H]+)
1H NMR (400 MHz, CDCl3) δ ppm: 7.86 (d, J=4.0 Hz, 1H), 7.00 (d, J=4.0 Hz, 1H), 4.17 (s, 3H)
Example 11
Production of 2-(4-bromo-3-thienyl)-6-fluoro-4-methoxy-5-(trifluoromethyl)pyrimidine
0.4 g of a crude purified product of 4-bromo-3-amidinothiophene hydrochloride was dissolved in 15 ml of acetonitrile, to this were added 0.4 g (1.9 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.0 g (7.7 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 19.8 hours. After stirring, the reaction solution was purified by a column to obtain 0.1 g (0.2 mmol) of the compound represented by the following formula (16). The 3-step yield of the obtained compound was 4.2%.
Figure US12435076-20251007-C00029
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 357.7 ([M+H]+)
1H NMR (400 MHz, CDCl3) δ ppm: 8.38 (d, J=3.7 Hz, 1H), 7.42 (d, J=3.7 Hz, 1H), 4.25 (s, 3H)
Example 12
Production of 6-fluoro-2-(5-iodo-2-thienyl)-4-methoxy-5-(trifluoromethyl)pyrimidine
0.6 g (2.1 mmol) of 5-iodo-2-amidinothiophene hydrochloride was dissolved in 21 ml of acetonitrile, to this were added 0.5 g (2.4 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.4 g (10.8 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 19 hours. After stirring, the reaction solution was purified by a column to obtain 0.5 g (1.2 mmol) of the compound represented by the following formula (17). The isolated yield of the obtained compound was 58.2%.
Figure US12435076-20251007-C00030
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 403.6 ([M+H]+)
1H NMR (400 MHz, CDCl3) δ ppm: 7.69 (d, J=4.0 Hz, 1H), 7.33 (d, J=4.0 Hz, 1H), 4.17 (s, 3H)
Example 13
Production of 6-fluoro-4-methoxy-5-(trifluoromethyl)-2-[4-(trifluoromethyl)-2-thiazolyl]pyrimidine
0.5 g (2.1 mmol) of 4-(trifluoromethyl)-1,3-thiazole-2-carboxyimideamide hydrochloride was dissolved in 22 ml of acetonitrile, to this were added 0.6 g (2.8 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.5 g (11.6 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 20.2 hours. After stirring, the reaction solution was purified by a column to obtain 0.2 g (0.6 mmol) of the compound represented by the following formula (18). The isolated yield of the obtained compound was 27.1%.
Figure US12435076-20251007-C00031
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 347.0 ([M−H]−)
1H NMR (400 MHz, CDCl3) δ ppm: 8.04 (s, 1H), 4.29 (s, 1H)
Example 14
Production of 6-fluoro-4-methoxy-2-(4-methyl-2-thiazolyl)-5-(trifluoromethyl)pyrimidine
0.2 g (1.7 mmol) of 4-methyl-2-amidino-1,3-thiazole hydrochloride was dissolved in 42 ml of acetonitrile, to this were added 0.5 g (2.3 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.4 g (10.8 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 23.2 hours. After stirring, the reaction solution was purified by a column to obtain 0.6 g (2.0 mmol) of the compound represented by the following formula (19). The isolated yield of the obtained compound was 49.1%.
Figure US12435076-20251007-C00032
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 293.1 ([M+H]+)
1H NMR (400 MHz, CDCl3) δ ppm: 7.23 (d, J=0.9 Hz, 1H), 4.25 (s, 3H), 2.61 (d, J=0.9 Hz, 3H)
Example 15
Production of 6-fluoro-4-methoxy-2-(2-methyl-4-thiazolyl)-5-(trifluoromethyl)pyrimidine
0.2 g (1.7 mmol) of 2-methyl-4-amidinothiazole hydrochloride was dissolved in 17 ml of acetonitrile, to this were added 0.5 g (2.4 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.2 g (9.3 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 22.3 hours. After stirring, the reaction solution was purified by a column to obtain 0.2 g (0.8 mmol) of the compound represented by the following formula (20). The isolated yield of the obtained compound was 46.6%.
Figure US12435076-20251007-C00033
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 293.2 ([M+H]+)
1H NMR (400 MHz, CDCl3) δ ppm: 8.31 (s, 1H), 4.23 (s, 3H), 2.84 (s, 3H)
Example 16
Production of 6-fluoro-4-methoxy-2-(5-nitro-2-thienyl)-5-(trifluoromethyl)pyrimidine
0.7 g of a crude purified product of 5-nitro-2-amidinothiophene hydrochloride was dissolved in 33 ml of acetonitrile, to this were added 0.8 g (3.8 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 2.2 g (17.0 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 21 hours. After stirring, the reaction solution was purified by a column to obtain 0.2 g (0.6 mmol) of the compound represented by the following formula (21). The 3-step yield of the obtained compound was 19%.
Figure US12435076-20251007-C00034
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 322.3 ([M−H]−)
1H NMR (400 MHz, CDCl3) δ ppm: 7.97 (d, J=4.3 Hz, 1H), 7.94 (d, J=4.3 Hz, 1H), 4.23 (s, 3H)
Example 17
Production of 6-fluoro-4-methoxy-2-[5-(methylsulfanyl)-2-thienyl]-5-(trifluoromethyl)pyrimidine
0.5 g (2.4 mmol) of 5-(methylsulfanyl)thiophene-2-carboxyimideamide hydrochloride was dissolved in 24 ml of acetonitrile, to this were added 0.6 g (2.8 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.6 g (12.4 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 18.3 hours. After stirring, the reaction solution was purified by a column to obtain 0.5 g (1.6 mmol) of the compound represented by the following formula (22). The isolated yield of the obtained compound was 67.6%.
Figure US12435076-20251007-C00035
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 324.0 ([M+H]+)
1H NMR (400 MHz, CDCl3) δ ppm: 7.91 (d, J=4.0 Hz, 1H), 6.99 (d, J=4.0 Hz, 1H), 4.17 (s, 3H), 2.62 (s, 3H).
Example 18
Production of 6-fluoro-2-[5-(methanesulfonyl)-2-thienyl]-4-methoxy-5-(trifluoromethyl)pyrimidine
0.5 g (2.1 mmol) of 5-methanesulphonyl-2-amidinothiophene hydrochloride was dissolved in 21 ml of acetonitrile, to this were added 0.5 g (2.3 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.4 g (10.8 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 13.5 hours. After stirring, the reaction solution was purified by a column to obtain 0.3 g (0.9 mmol) of the compound represented by the following formula (23). The isolated yield of the obtained compound was 45.3%.
Figure US12435076-20251007-C00036
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 355.5 ([M−H]−)
1H NMR (400 MHz, CDCl3) δ ppm: 8.03 (d, J=4.0 Hz, 1H), 7.74 (d, J=4.0 Hz, 1H), 4.21 (s, 3H), 3.24 (s, 3H)
Example 19
Production of 2-[2-(dimethylamino)-5-thiazolyl]-6-fluoro-4-methoxy-5-(trifluoromethyl)pyrimidine
0.1 g (0.7 mmol) of 2-(dimethylamino)-5-amidino-1,3-thiazole hydrochloride was dissolved in 7 ml of acetonitrile, to this were added 0.2 g (0.9 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 0.5 g (3.9 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 18.3 hours. After stirring, the reaction solution was purified by a column to obtain 0.1 g (0.2 mmol) of the compound represented by the following formula (24). The isolated yield of the obtained compound was 27.0%.
Figure US12435076-20251007-C00037
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 323.1 ([M+H]+)
1H NMR (400 MHz, CDCl3) δ ppm: 8.19 (s, 1H), 4.12 (s, 3H), 3.22 (s, 6H)
Example 20
Production of 6-fluoro-4-methoxy-2-(2-methoxy-5-thiazolyl)-5-(trifluoromethyl)pyrimidine
0.6 g (3.3 mmol) of 2-methoxy-5-amidino-1,3-thiazole hydrochloride was dissolved in 33 ml of acetonitrile, to this were added 0.8 g (3.7 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 2.2 g (17.0 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 19.5 hours. After stirring, the reaction solution was purified by a column to obtain 0.2 g (0.8 mmol) of the compound represented by the following formula (25). The isolated yield of the obtained compound was 23.7%.
Figure US12435076-20251007-C00038
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 310.2 ([M+H]+)
1H NMR (400 MHz, CDCl3) δ ppm: 7.76 (s, 1H), 4.13 (s, 3H), 3.46 (s, 3H)
Example 21
Production of 6-fluoro-4-methoxy-2-[5-(methoxycarbonyl)-2-thienyl]-5-(trifluoromethyl)pyrimidine
0.6 g (2.8 mmol) of methyl 5-amidinothiophene-2-carboxylate hydrochloride was dissolved in 28 ml of acetonitrile, to this were added 0.7 g (3.3 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.9 g (14.7 mmol) of N,N-diisopropylethylamine, and the mixture was stirred at room temperature for 20.8 hours. After stirring, the reaction solution was purified by a column to obtain 0.6 g (1.6 mmol) of the compound represented by the following formula (26). The isolated yield of the obtained compound was 60.0%.
Figure US12435076-20251007-C00039
The analysis results were as follows.
Mass Spectrum (APCI, m/z): 335.3 ([M−H]−)
1H NMR (400 MHz, CDCl3) δ ppm: 8.01 (d, J=4.0 Hz, 1H), 7.80 (d, J=4.0 Hz, 1H), 4.21 (s, 3H), 3.94 (s, 3H)
Test Example of Biological Activity
Evaluation Test for Rice Blast
6-fluoro-4-methoxy-2-(2-thiazolyl)-5-(trifluoromethyl)pyrimidine prepared in Example 3 was dissolved in acetone to prepare a solution having a concentration of 100,000 ppm. Next, to 1 ml of this acetone solution was added sterilized water to make 50 ml to prepare a test solution having a concentration of 2,000 ppm. Further, to 10 ml of a separately prepared test solution having a concentration of 2,000 ppm was added sterilized water to make 20 ml to prepare a test solution having a concentration of 1,000 ppm. 1,000 l of the test solution having a concentration of 2,000 ppm and of the test solution having a concentration of 1,000 ppm were each added dropwise to a separately fabricated oatmeal culture medium, and air-dried. Subsequently, a 4-mm rice blast disc was placed such that flora contacted a treated surface of the oatmeal culture medium. Then, the oatmeal culture medium was allowed to stand still in a thermostatic room at 25° C. for 6 days, and an elongation length of hyphae was then investigated. The results are shown in Table 1. The control value was calculated according to the following expression. In the following expression, “without treatment” means that 1 ml of acetone was diluted with sterilized water to 50 ml as a test solution, and the solution was added dropwise to the culture medium. In addition, “with treatment” means that a test solution that had been diluted and adjusted to a set concentration was added dropwise to the culture medium.
[Table 1]
TABLE 1
Concentration of test solution
(ppm) Control value
2000 100
1000 68

Control value={(average of elongation lengths of hyphae without treatment−average of elongation lengths of hyphae with treatment)/average of elongation lengths of hyphae without treatment}×100  [Expression 1]
As shown in Table 1, the fluorine-containing pyrimidine compound of the present disclosure exhibits the control activity against the pathogens of rice blast, and is found to be effective as a compound exhibiting a biological activity.

Claims (6)

What is claimed is:
1. A fluorine-containing pyrimidine compound represented by the following formula (1), (2) or (3):
Figure US12435076-20251007-C00040
wherein
R represents a hydrocarbon group having 1 to 12 carbon atoms,
X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA1, —SOmA1 where m is an integer of 0 to 3, —NA1A2, —COOA1 or —CONA1A2,
Z represents CW or N,
W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA1, —SOmA1 where m is an integer of 0 to 3, —NA1A2, —COOA1 or —CONA1A2, and
A1 and A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
2. The fluorine-containing pyrimidine compound according to claim 1, wherein R is an alkyl group having 1 to 10 carbon atoms.
3. A method for producing a fluorine-containing pyrimidine compound represented by the formula (1), (2), or (3), comprising:
(a) a step of reacting a fluoroisobutylene derivative represented by the following formula (4) with a compound represented by the following formula (5) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (1):
Figure US12435076-20251007-C00041
(b) a step of reacting a fluoroisobutylene derivative represented by the following formula (4) with a compound represented by the following formula (6) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (2):
Figure US12435076-20251007-C00042
or
(c) a step of reacting a fluoroisobutylene derivative represented by the following formula (4) with a compound represented by the following formula (7) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (3):
Figure US12435076-20251007-C00043
wherein
R represents a hydrocarbon group having 1 to 12 carbon atoms, X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA1, —SOmA1 where m is an integer of 0 to 3, —NA1A2, —COOA1 or —CONA1A2,
Z represents CW or N,
W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA1, —SOmA1 where m is an integer of 0 to 3, —NA1A2, —COOA1 or —CONA1A2, and
A1 and A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
4. A method for producing a fluorine-containing pyrimidine compound represented by the formula (1), (2), or (3), comprising:
(d) a step of reacting a fluoroisobutane derivative represented by the following formula (8) with a compound represented by the following formula (5) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (1):
Figure US12435076-20251007-C00044
(e) a step of reacting a fluoroisobutane derivative represented by the following formula (8) with a compound represented by the following formula (6) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (2):
Figure US12435076-20251007-C00045
or
(f) a step of reacting a fluoroisobutane derivative represented by the following formula (8) with a compound represented by the following formula (7) or a salt thereof to obtain a fluorine-containing pyrimidine compound of the following formula (3):
Figure US12435076-20251007-C00046
wherein
Q represents a halogen atom, —OA1, —SOmA1 where m is an integer of 0 to 3, or —NA1A2,
R represents a hydrocarbon group having 1 to 12 carbon atoms, X and Y each independently represent a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA1, —SOmA1 where m is an integer of 0 to 3, —NA1A2, —COOA1 or —CONA1A2,
Z represents CW or N,
W represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, —CnF2n+1 where n is an integer of 1 to 10, a nitro group, a boronic acid group, —OA1, —SOmA1 where m is an integer of 0 to 3, —NA1A2, —COOA1 or —CONA1A2, and
A1 and A2 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
5. The method for producing a fluorine-containing pyrimidine compound according to claim 3, wherein R is an alkyl group having 1 to 10 carbon atoms.
6. The method for producing a fluorine-containing pyrimidine compound according to claim 4, wherein R is an alkyl group having 1 to 10 carbon atoms.
US17/768,556 2019-11-01 2020-10-29 Fluorine-containing pyrimidine compound and method for producing same Active 2041-12-11 US12435076B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019200237 2019-11-01
JP2019-200237 2019-11-01
PCT/JP2020/040682 WO2021085550A1 (en) 2019-11-01 2020-10-29 Fluorinated pyrimidine compound and method for manufacturing same

Publications (2)

Publication Number Publication Date
US20240124436A1 US20240124436A1 (en) 2024-04-18
US12435076B2 true US12435076B2 (en) 2025-10-07

Family

ID=75716366

Family Applications (1)

Application Number Title Priority Date Filing Date
US17/768,556 Active 2041-12-11 US12435076B2 (en) 2019-11-01 2020-10-29 Fluorine-containing pyrimidine compound and method for producing same

Country Status (5)

Country Link
US (1) US12435076B2 (en)
EP (1) EP4053123A4 (en)
JP (1) JP7085697B2 (en)
CN (1) CN114502551B (en)
WO (1) WO2021085550A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026048597A1 (en) * 2024-08-27 2026-03-05 ユニマテック株式会社 Fluorine-containing pyrimidine compound, fluorine-containing pyrimidinone compound, and bactericide

Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59104364A (en) 1982-12-03 1984-06-16 Nippon Mektron Ltd Novel pyrimidine derivative and its preparation
JPS63216877A (en) 1987-03-06 1988-09-09 Nippon Kayaku Co Ltd Fluorine-containing pyrimidine derivative
WO1994029300A1 (en) 1993-06-07 1994-12-22 Rhone Poulenc Agrochimie Pyrazole fungicides 3-substituted by a heterocyclic ring
JPH07196628A (en) 1993-12-28 1995-08-01 Nippon Mektron Ltd New pyrimidine derivatives and their production
EP0819690A2 (en) 1996-07-15 1998-01-21 American Cyanamid Company Herbicidal 6-thienyl and 4-thienyl pyrimidines
US5922726A (en) 1996-07-15 1999-07-13 American Cyanamid Company Herbicidal 6-thienyl pyridines and 4-thienyl pyrimidines
JP2000001460A (en) 1998-06-11 2000-01-07 Sumitomo Chem Co Ltd Acrylic acid derivatives and their uses
EP1334956A2 (en) 2002-02-07 2003-08-13 Sumitomo Chemical Company, Limited Method for preparing sulfone or sulfoxide compound
EP1364946A1 (en) 2001-02-08 2003-11-26 Kumiai Chemical Industry Co., Ltd. Isoxazoline derivative and herbicide comprising the same as active ingredient
WO2006005571A1 (en) 2004-07-14 2006-01-19 Basf Aktiengesellschaft 2-substituted pyrimidines, method for their production and their use for controlling pathogenic fungi
WO2009129905A1 (en) 2008-04-21 2009-10-29 Merck Patent Gmbh Pyridazinone derivatives
WO2009138712A2 (en) 2008-05-13 2009-11-19 Syngenta Limited Chemical compounds
WO2011019405A1 (en) 2009-08-14 2011-02-17 Vertex Pharmaceuticals Incorporated Pyrimidine compounds as tuberculosis inhibitors
CA2781404A1 (en) 2009-11-26 2011-06-03 Basf Se Method for producing 5,5-disubstituted 4,5-dihydroisoxazol-3-thiocarboxamidine salts
WO2012027236A1 (en) 2010-08-23 2012-03-01 Schering Corporation NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
WO2012098049A1 (en) 2011-01-18 2012-07-26 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of statins in the presence of base
US20130090476A1 (en) 2009-06-23 2013-04-11 Bayer Cropscience Ag Thiazolylpiperidine Derivatives as Fungicides
US8445408B2 (en) 2008-12-30 2013-05-21 Bayer Cropscience Ag Pyrimidine derivatives and their use for controlling undesired plant growth
WO2013086131A1 (en) 2011-12-06 2013-06-13 The Trustees Of The University Of Pennsylvania Inhibitors targeting drug-resistant influenza a
US20160038784A1 (en) 2014-08-07 2016-02-11 Xiamen Aolro Technology Co., Ltd. Treadboard of a treadmill and a treadmill
WO2017139603A1 (en) 2016-02-12 2017-08-17 Astrazeneca Ab Halo-substituted piperidines as orexin receptor modulators
CN109503562A (en) 2018-12-26 2019-03-22 西华大学 2- [4- (2- thienyl)] pyrimidine radicals urea derivative and its preparation method and application
US20190135793A1 (en) 2017-05-18 2019-05-09 Board Of Regents, The University Of Texas System Heterocyclic inhibitors of kdm5 for the treatment of disease
CN109942561A (en) 2018-12-26 2019-06-28 西华大学 4-(2-Thienyl)pyrimidine derivatives, preparation method and application thereof
WO2020116296A1 (en) 2018-12-07 2020-06-11 ユニマテック株式会社 Fluorinated pyrimidine compound and production method therefor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017015456A (en) 2015-06-01 2018-11-29 Bantam Pharmaceutical Llc Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto.
KR102674973B1 (en) * 2018-12-07 2024-06-14 삼성전자주식회사 Electronic device for detecting location of user and method thereof

Patent Citations (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59104364A (en) 1982-12-03 1984-06-16 Nippon Mektron Ltd Novel pyrimidine derivative and its preparation
JPS63216877A (en) 1987-03-06 1988-09-09 Nippon Kayaku Co Ltd Fluorine-containing pyrimidine derivative
WO1994029300A1 (en) 1993-06-07 1994-12-22 Rhone Poulenc Agrochimie Pyrazole fungicides 3-substituted by a heterocyclic ring
JPH07196628A (en) 1993-12-28 1995-08-01 Nippon Mektron Ltd New pyrimidine derivatives and their production
EP0819690A2 (en) 1996-07-15 1998-01-21 American Cyanamid Company Herbicidal 6-thienyl and 4-thienyl pyrimidines
US5747423A (en) 1996-07-15 1998-05-05 American Cyanamid Company Herbicidal 6-thienyl and 4-thienyl pyrimidines
US5922726A (en) 1996-07-15 1999-07-13 American Cyanamid Company Herbicidal 6-thienyl pyridines and 4-thienyl pyrimidines
JP2000001460A (en) 1998-06-11 2000-01-07 Sumitomo Chem Co Ltd Acrylic acid derivatives and their uses
EP1364946A1 (en) 2001-02-08 2003-11-26 Kumiai Chemical Industry Co., Ltd. Isoxazoline derivative and herbicide comprising the same as active ingredient
US20040110749A1 (en) 2001-02-08 2004-06-10 Masao Nakatani Isoxazoline derivative and herbicide comprising the same as active ingredient
EP1334956A2 (en) 2002-02-07 2003-08-13 Sumitomo Chemical Company, Limited Method for preparing sulfone or sulfoxide compound
US20030171589A1 (en) 2002-02-07 2003-09-11 Sumitomo Chemical Company, Limited Method for preparing sulfone or sulfoxide compound
WO2006005571A1 (en) 2004-07-14 2006-01-19 Basf Aktiengesellschaft 2-substituted pyrimidines, method for their production and their use for controlling pathogenic fungi
US20080132522A1 (en) 2004-07-14 2008-06-05 Basf Aktiengesellschaft 2-Substituted Pyrimidines, Method for Their Production and Their Use for Controlling Pathogenic Fungi
WO2009129905A1 (en) 2008-04-21 2009-10-29 Merck Patent Gmbh Pyridazinone derivatives
US20110034474A1 (en) 2008-04-21 2011-02-10 Merck Patent Gesellschaft Mit Beschrankter Haftung Pyridazinone derivatives
US20110136666A1 (en) 2008-05-13 2011-06-09 Syngenta Crop Protection, Inc. Chemical compounds
WO2009138712A2 (en) 2008-05-13 2009-11-19 Syngenta Limited Chemical compounds
US8445408B2 (en) 2008-12-30 2013-05-21 Bayer Cropscience Ag Pyrimidine derivatives and their use for controlling undesired plant growth
US20130090476A1 (en) 2009-06-23 2013-04-11 Bayer Cropscience Ag Thiazolylpiperidine Derivatives as Fungicides
US20140249137A1 (en) 2009-08-14 2014-09-04 Vertex Pharmaceuticals Incorporated Pyrimidine compounds as tuberculosis inhibitors
US20110053916A1 (en) 2009-08-14 2011-03-03 Vertex Pharmaceuticals Incorporated Pyrimidine compounds as tuberculosis inhibitors
WO2011019405A1 (en) 2009-08-14 2011-02-17 Vertex Pharmaceuticals Incorporated Pyrimidine compounds as tuberculosis inhibitors
CA2781404A1 (en) 2009-11-26 2011-06-03 Basf Se Method for producing 5,5-disubstituted 4,5-dihydroisoxazol-3-thiocarboxamidine salts
US20120264947A1 (en) 2009-11-26 2012-10-18 Basf Se Method for Producing 5,5-Disubstituted 4,5-Dihydroisoxazol-3-Thiocarboxamidine Salts
WO2012027236A1 (en) 2010-08-23 2012-03-01 Schering Corporation NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
US20130150362A1 (en) 2010-08-23 2013-06-13 Merck Sharp & Dohme Corp. NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
WO2012098049A1 (en) 2011-01-18 2012-07-26 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of statins in the presence of base
US20130296561A1 (en) 2011-01-18 2013-11-07 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of statins in the presence of base
WO2013086131A1 (en) 2011-12-06 2013-06-13 The Trustees Of The University Of Pennsylvania Inhibitors targeting drug-resistant influenza a
US20160038784A1 (en) 2014-08-07 2016-02-11 Xiamen Aolro Technology Co., Ltd. Treadboard of a treadmill and a treadmill
WO2016019644A1 (en) 2014-08-07 2016-02-11 厦门奥力龙科技有限公司 Running board for running machine and running machine using same
US20160361589A1 (en) 2014-08-07 2016-12-15 Xiamen Aolro Technology Co., Ltd. Treadboard of a treadmill and a treadmill
WO2017139603A1 (en) 2016-02-12 2017-08-17 Astrazeneca Ab Halo-substituted piperidines as orexin receptor modulators
US20190135800A1 (en) 2016-02-12 2019-05-09 Astrazeneca Ab Halo-substituted piperidines as orexin receptor modulators
US20190135793A1 (en) 2017-05-18 2019-05-09 Board Of Regents, The University Of Texas System Heterocyclic inhibitors of kdm5 for the treatment of disease
WO2020116296A1 (en) 2018-12-07 2020-06-11 ユニマテック株式会社 Fluorinated pyrimidine compound and production method therefor
US20210403455A1 (en) 2018-12-07 2021-12-30 Unimatec Co., Ltd. Fluorine-containing pyrimidine compound and method for manufacturing the same
CN109503562A (en) 2018-12-26 2019-03-22 西华大学 2- [4- (2- thienyl)] pyrimidine radicals urea derivative and its preparation method and application
CN109942561A (en) 2018-12-26 2019-06-28 西华大学 4-(2-Thienyl)pyrimidine derivatives, preparation method and application thereof

Non-Patent Citations (16)

* Cited by examiner, † Cited by third party
Title
Bin Yang et al., "Visible-Light Photoredox Decarboxylation of Perfluoroarenelodine(III) Trifluoroacetates for C—H Trifluoromethylation of (Hetero)arenes", American Chemical Society, ACS Catalysis, vol. 8, pp. 2839-2843, Mar. 1, 2018.
Decision of Refusal issued in corresponding Chinese Patent Application No. 202080070690.1 dated Mar. 17, 2023, with English translation (9 Pages).
Extended European Search Report issued in corresponding European Patent Application No. 20880783.4 dated Sep. 8, 2023 (7 Pages).
International Preliminary Report on Patentability for corresponding International Application No. PCT/JP2020/040682 dated Dec. 22, 2020, with English translation (7 Pages).
International Search Report for corresponding International Application No. PCT/JP2020/040682 dated Dec. 22, 2020 (7 Pages).
Kandasamy Jeyakumar et al., "Simple and Efficient Method for the Oxidation of Sulfides to Sulfones Using Hydrogen Peroxide and a Mo(VI) Based Catalyst", Catalysis Communications 10 (2009), pp. 1948-1951.
Office Action for corresponding European Patent Application No. 20880783.4 dated Aug. 18, 2025 (4 Pages).
Office Action issued for the corresponding Chinese Patent Application No. 202080070690.1; dated Jul. 6, 2022 (total 12 pages).
Office Action issued in corresponding Indian Patent Application No. 202237027146, dated Feb. 14, 2023, with English translation (5 pages).
Pei-Zhi Zhang et al., "Direct Regioselective Csp2-H Trifluoromethylation of Pyrimidinones and Pyridinones", Science Direct, Tetrahedron, vol. 72, Issue 23, pp. 3250-3255, Jun. 9, 2016.
Second Office Action issued in corresponding Chinese Patent Application No. 202080070690.1 dated Jan. 3, 2023. with English translation (11 Pages).
Siva Prasad Das et al., "Selective Oxidation of Organic Sulfides by Mononuclear and Dinuclear Peroxotungsten(VI) Complexes" Tetrahedron Letters 53 (2012), pp. 1163-1168.
Third Party Observation issued in corresponding European Patent Application No. 20880783.4, dated Mar. 6, 2023 (9 pages).
Written Opinion for corresponding International Application No. PCT/JP2020/040682 dated Dec. 22, 2020, with English translation (6 Pages).
Y. Inouye et al., "A Facile One-pot Preparation of 2-Methyl- and 2-Phenyl -4 fluoro-5-trifluoromethyl-6-methoxypyrimidinefrom methyl 2-hydryl-2-(perfluoromethyl)perfluoropropylether", Journal of Fluorine Chemistry, vol. 27, No. 2, pp. 231-236, Oct. 20, 1984.
Yao Ouyang et al., "Trifluoromethanesulfonic Anhydride as a Low-Cost and Versatile Trifluoromethylation Reagent", European Journal of Organic Chemistry, Angewandte Chemie International Edition, vol. 57, Issue 23, pp. 6926-6929, Apr. 19, 2018.

Also Published As

Publication number Publication date
JP7085697B2 (en) 2022-06-16
EP4053123A1 (en) 2022-09-07
CN114502551B (en) 2023-08-22
EP4053123A4 (en) 2023-10-11
WO2021085550A1 (en) 2021-05-06
CN114502551A (en) 2022-05-13
US20240124436A1 (en) 2024-04-18
JPWO2021085550A1 (en) 2021-05-06

Similar Documents

Publication Publication Date Title
JP6802416B2 (en) Fluorine-containing pyrimidine compound and its production method
US12435076B2 (en) Fluorine-containing pyrimidine compound and method for producing same
US12583847B2 (en) Fluorinated pyrimidine compound and method for producing same
CN1161342C (en) Process for preparing substituted pyrimidines
US12358894B2 (en) Fluorine-containing pyrimidine compound and method for producing same
WO2022166837A1 (en) Aryl sulfide, preparation method therefor, and application thereof
US12371422B2 (en) Fluorine-containing pyrimidine compound and manufacturing method for same
US12503457B2 (en) Fluorine-containing pyrimidine compound, and method for producing same
US6281358B1 (en) Process for the preparation of substituted pyrimidines
CN1035254C (en) Substituted thiophene carboxamides
JP7649872B2 (en) Fluorine-containing pyrazole compound and method for producing same
US20230096085A1 (en) Fluorine-containing pyrimidine compound and production method therefor
JP6479486B2 (en) 4-alkoxy-5- (trifluoromethyl) pyrimidine derivative and method for producing the same
US9527820B1 (en) Diethylammonium salts of phenyl-substituted thiobarbituric acid as anti-diabetic agents
CN102627535A (en) Preparation method for compound containing 1,1-diphenyl cyclopropyl structure
CN101402632A (en) Aryl hydrazide compounds with antineoplastic activity
JPS58134089A (en) 1,3-dioxolane benzoate derivative and preparation thereof
JPH052673B2 (en)
JPS6067447A (en) 2,2-dichloro-3,3-dimethylcyclopropylmethylamine and production thereof

Legal Events

Date Code Title Description
AS Assignment

Owner name: UNIMATEC CO., LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SEINO, JUNYA;AOTSU, RIE;KOKIN, KEISUKE;REEL/FRAME:059584/0140

Effective date: 20220307

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: AWAITING TC RESP., ISSUE FEE NOT PAID

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE